HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Meglumine gadobenate

HCID 197281
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
127000-20-8
Standard SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])C(COCc1ccccc1)C(=O)[O-].[Gd+3].[H+].[H+]
InChIKey
OCDAWJYGVOLXGZ-VPVMAENOSA-K
Molecular formula
C36H62GdN5O21
Average molar mass
1,058.1 g/mol
Monoisotopic mass
1,058.31784

Overview

See also: Gadobenate Dimeglumine (preferred); Gadolinium Cation (3+) (has active moiety).

Names & identifiers

Preferred name
Meglumine gadobenate
IUPAC
2-[2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);hydron;bis((2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol)
English name
GADOBENATE DIMEGLUMINE
Molecular formula
C29H44GdN4O16-
Molecular weight
861.93

Names & synonyms

Meglumine gadobenate (JAN)Gadobenate dimeglumine (USAN)Gadobenate Dimeglumine [USAN]MEGLUMINE GADOBENATE [JAN]Meglumine gadobenateSCHEMBL1650024GADOBENATE DIMEGLUMINE [MI]GADOBENATE DIMEGLUMINE [HSDB]MEGLUMINE GADOBENATE [MART.]GADOBENATE DIMEGLUMINE [VANDF]GADOBENOATE DIMEGLUMINE [VANDF]GADOBENIC ACID MEGLUMINE [WHO-DD]
Show more names
Multihance MultipackGadobete DimeglumineGADOBENATE DIMEGLUMINEGadobenic acid dimeglumineMetmeglumine gadolinium betateD-Glucitol, 1-deoxy-1-(methylamino)-, [4-(carboxy-κO)-5,8,11-tris[(carboxy-κO)methyl]-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)-κN5,κN8,κN11,κO13]gadolinate(2-) (2:1)2-[2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]-3-phenylmethoxypropanoate,gadolinium(3+),hydron,(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
GADOBENATE DIMEGLUMINE [ORANGE BOOK]D04283GADOBENIC ACID (AS MEGLUMINE GADOBENATE)D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)-, (4-CARBOXY-5,8,11-TRIS(CARBOXYMETHYL)-1-PHENYL-2-OXA-5,8,11-TRIAZATRIDECAN-13- OATO(5-)-N(SUP 5),N(SUP 8),N(SUP 11),O(SUP 4),O(SUP 5),O(SUP 8), O(SUP 11),O(SUP 13)-GADOLINATE(2-) (2:1)DIHYDROGEN ((+/-)-4-CARBOXY-5,8,11-TRIS(CARBOXYMETHYL)-1-PHENYL-2-OXA-5,8,11-TRIAZATRIDECAN-13-OATO(5-))GADOLINATE(2-), COMPOUND WITH 1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL (1:2)Gadolinium hydrogen 4-carboxylato-5,8,11-tris(carboxylatomethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oate--1-deoxy-1-(methylamino)-D-glucitol (1/2/1/2)

Properties

Computed structural properties

Topological polar surface area
446 Ų
Hydrogen bond donors
14
Hydrogen bond acceptors
26
Rotatable bonds
27
Heavy atoms
63
Formal charge
0
Complexity
833

Physicochemical properties

Melting point
124 ° · 124°
alpha
36520 · 36520 -26.9° (c = 1.45 in water)
Density
20 · d20 1.22
NCI Dictionary of Cancer Terms
gadobenate dimeglumine
FDA UNII
3 Q6PPC19PO · 3Q6PPC19PO
NCI Drug Dictionary
gadobenate dimeglumine
Hazardous Substances Data
127000 · 127000-20-8(Hazardous Substances Data)
Toxicity
50 i.v · LD50 i.v. in mice (mmol/kg): 5.7 (at 1 mL/min), 7.9 (at 0.2 mL/min); LD50 i.v. in rats (mmol/kg): 6.6 (at 6 mL/min), 9.2 (at 1 mL/min) (Morisetti)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Toxicity
LD50 i.v. in mice (mmol/kg): 5.7 (at 1 mL/min), 7.9 (at 0.2 mL/min); LD50 i.v. in rats (mmol/kg): 6.6 (at 6 mL/min), 9.2 (at 1 mL/min) (Morisetti)
Hazardous Substances Data
127000-20-8(Hazardous Substances Data)

Chemistry & industry

Applications · 2 items

UsesDiagnostic aid (paramagnetic).

General DescriptionGadobenatedimeglumine is an ionic, clear, colorless, gadoliniumcontainingsolution. This salt solution has 6.9 times the osmolalityof plasma. It is indicated to enhance the visualization ofcentral nervous system (CNS) lesions associated with an abnormalblood-brain barrier or abnormal vascularity of thebrain, spine, or associated tissues when using T1-weightedsequences.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes

Database identifiers

CAS
127000-20-8
PubChem CID
197281
DTXSID
DTXSID20925761
UNII
3Q6PPC19PO